Brandon Smith
Partner at Childers, Schlueter & Smith, LLC
I’m M. Brandon Smith, a partner at Childers, Schlueter & Smith in Atlanta, Georgia, helping injured people nationwide with pharmaceutical litigation, mass torts, product liability, and serious personal injury cases.
Posts
-
The Past, Present, and Future of Hernia Mesh Litigation in the U.S.
Today, many thousands of consumers have filed lawsuits against hernia surgical mesh implant manufacturers. Big name pharmaceutical companies like C.R. Bard, Johnson & Johnson/Ethicon, Atrium and others are the focus in these lawsuits for the debilitating medical side effects that resulted from their
-
An Overview of the Risks Associated With Hernia Surgical Mesh Implants
Hernia surgical mesh implants are used to reduce hernia recurrence and provide support to tissue that is weakened or damaged because of a hernia. Hernias occur when an organ, intestine, or fatty tissue breaks through the wall of whatever is containing it, and can happen…
-
IVC Filters May Increase Mortality Rate in Patients Over 65
When an elderly individual suffers from a pulmonary embolism (PE), approximately one in six of them receive inferior vena cava (IVC) filters to decrease their risk of having subsequent PE. PE occurs when an artery in the lungs becomes blocked by a blood clot, which…
-
Lawsuits, Side Effects, and Updates on Xarelto Litigation
With thousands of reported side effects, the blood thinning drug Xarelto has been controversial since its initial approval for medical use in 2011. Nevertheless, Johnson & Johnson (J&J) submitted a Supplemental New Drug Application on Dec. 14 for Xarelto to be used as a preventative…
-
‘Rhino’ Male Enhancers Tainted with Dangerous, Unlisted Drugs
The FDA recently issued a warning dissuading customers from using Rhino male sexual enhancement products, which are unregulated supplements typically found for sale at gas stations and convenience stores. This warning comes after the discovery that many Rhino supplements contain unlisted ingredients
-
FDA to Replace Current Medical Device Approval System
The FDA recently announced plans to overhaul its dated medical device approval system. The system, which has been in place since the 1970s, has been criticized for years due to its approval of over 95 percent of medical devices to be put on the U.S.…
-
Valsartan Medication May Be Causing Drug-Induced Angioedema
In July, the Food and Drug Administration (FDA) issued a voluntary recall of multiple medications containing valsartan that were manufactured by the Chinese pharmaceutical company, Zhejiang Huahai. The recall occurred after two likely carcinogenic chemicals, N-nitrosodimethylamine (NDMA) and N-Nitr
-
Valsartan Recalled After Testing Positive for Potentially Cancer-Causing Chemicals
Beginning in July, the U.S. Food and Drug Administration (FDA) has issued a series of recalls for multiple medications that contain the drug valsartan after two likely carcinogenic chemicals were found in valsartan batches that had been imported to the United States from China. Often…
-
Hernia Mesh Complications Can Also Cause Mental and Emotional Issues
Today, hernia mesh manufacturers such as Johnson & Johnson, Atrium, Covidien, and C.R. Bard, Inc., are the target of thousands of lawsuits because of medical complications that occurred after hernia mesh implant surgery. These infections can include extreme pain, infection, recurrence of hernia, org
-
Big Pradaxa Verdict in Favor of Plaintiffs: $1,250,000
We are happy to report a jury in West Virginia just returned a $250,000 compensatory award to our deserving clients. The same jury awarded $1,000,000 more in punitives to punish Boehringer Ingelheim for their wanton and willful acts in handling its blood thinner Pradaxa. Led…
Subscribe to Brandon Smith
Get new posts delivered to your inbox.